Heisler M, Tierney E, Ackermann R T, Tseng C, Narayan K M Venkat, Crosson J, Waitzfelder B, Safford M M, Duru K, Herman W H, Kim C
Veterans Affairs Center for Practice Management and Outcomes Research, VA Ann Arbor Health System, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Chronic Illn. 2009 Sep;5(3):165-76. doi: 10.1177/1742395309339258. Epub 2009 Aug 12.
In participatory decision-making (PDM), physicians actively engage patients in treatment and other care decisions. Patients who report that their physicians engage in PDM have better disease self-management and health outcomes. We examined whether physicians' diabetes-specific treatment PDM preferences as well as their self-reported practices are associated with the quality of diabetes care their patients receive.
2003 cross-sectional survey and medical record review of a random sample of diabetes patients (n=4198) in 10 US health plans across the country and their physicians (n=1217). We characterized physicians' diabetes care PDM preferences and practices as 'no patient involvement,' 'physician-dominant,' 'shared,' or 'patient-dominant' and conducted multivariate analyses examining their effects on the following: (1) three diabetes care processes (annual hemoglobin A1c test; lipid test; and dilated retinal exam); (2) patients'satisfaction with physician communication; and (3) whether patients' A1c, systolic blood pressure (SBP), and low-density lipoprotein cholesterol (LDL) were in control.
Most physicians preferred 'shared' PDM (58%) rather than 'no patient involvement' (9%), 'physician-dominant' (28%) or 'patient dominant' PDM (5%). However, most reported practicing 'physician-dominant' PDM (43%) with most of their patients, rather than 'no patient involvement' (13%), 'shared' (37%) or 'patient-dominant' PDM (7%). After adjusting for patient and physician-level characteristics and clustering by health plan, patients of physicians who preferred 'shared' PDM were more likely to receive A1c tests [90% vs. 82%, AOR: 2.05, 95% CI: 1.03-3.07] and patients of physicians who preferred 'patient-dominant' treatment decision-making were more likely to receive lipid tests [60% vs. 50%, AOR: 1.58, 95% CI: 1.04-2.39] than those of providers who preferred 'no patient involvement' in treatment decision-making. There were no differences in patients' satisfaction with their doctor's communication or control of A1c, SBP or LDL depending on their physicians' PDM preferences. Physicians' self-reported PDM practices were not associated with any of the examined aspects of diabetes care in multivariate analyses.
Patients whose physicians prefer more patient involvement in decision-making are more likely than patients whose physicians prefer more physician-directed styles to receive some recommended risk factor screening tests, an important first step toward improved diabetes outcomes. Involving patients in treatment decision-making alone, however, appears not to be sufficient to improve biomedical outcomes.
在参与式决策(PDM)中,医生积极让患者参与治疗及其他护理决策。报告称其医生采用参与式决策的患者具有更好的疾病自我管理能力和健康结局。我们研究了医生对糖尿病特定治疗的参与式决策偏好及其自我报告的做法是否与患者接受的糖尿病护理质量相关。
对美国全国10个健康计划中的糖尿病患者(n = 4198)及其医生(n = 1217)的随机样本进行2003年横断面调查和病历审查。我们将医生对糖尿病护理的参与式决策偏好和做法分为“无患者参与”“医生主导”“共同参与”或“患者主导”,并进行多变量分析,以检验它们对以下方面的影响:(1)三个糖尿病护理流程(年度糖化血红蛋白检测、血脂检测和散瞳眼底检查);(2)患者对医生沟通的满意度;(3)患者的糖化血红蛋白、收缩压(SBP)和低密度脂蛋白胆固醇(LDL)是否得到控制。
大多数医生更喜欢“共同参与”式决策(58%),而非“无患者参与”(9%)、“医生主导”(28%)或“患者主导”式决策(5%)。然而,大多数医生报告称,他们与大多数患者采用“医生主导”式决策(43%),而非“无患者参与”(13%)、“共同参与”(37%)或“患者主导”式决策(7%)。在调整患者和医生层面的特征并按健康计划进行聚类后,与那些在治疗决策中更喜欢“无患者参与”的医生的患者相比,更喜欢“共同参与”式决策的医生的患者更有可能接受糖化血红蛋白检测[90%对82%,调整后比值比(AOR):2.05,95%置信区间(CI):1.03 - 3.07],而更喜欢“患者主导”治疗决策的医生的患者更有可能接受血脂检测[60%对50%,AOR:1.58,95% CI:1.04 - 2.39]。患者对医生沟通的满意度或糖化血红蛋白、收缩压或低密度脂蛋白的控制情况,在不同医生参与式决策偏好的患者之间没有差异。在多变量分析中,医生自我报告的参与式决策做法与糖尿病护理的任何一项检查方面均无关联。
与医生更喜欢更多由医生主导方式的患者相比,医生更喜欢患者更多参与决策的患者更有可能接受一些推荐的风险因素筛查测试,这是改善糖尿病结局的重要第一步。然而,仅让患者参与治疗决策似乎不足以改善生物医学结局。